Infectious Diseases
Pudu Robotics Announces Newly Released Puductor2 to Improve Public Health Safety
29/11/2020 — SHENZHEN, China — (BUSINESS WIRE) Pudo Robotics announced today the release of Puductor2, a technology-based, anti-pandemic robot. This newly designed intelligent robot has two disinfection modes of ultra-dry […]
Medicago Announces Positive Phase 1 Results for Its #COVID-19 Vaccine Candidate
100 per cent of subjects who received an adjuvanted vaccine candidate developed significant antibody and cellular immune responses after two doses 11/11/2020 — QUEBEC CITY, Quebec — (BUSINESS WIRE) Medicago, […]
PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19
Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection 27/10/2020 — WALTHAM, Mass. — (BUSINESS WIRE) PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 […]
UVDI Announces UV-C Device Presentations at the 16th World Congress on Public Health 2020
12/10/2020 — VALENCIA, Calif. — (BUSINESS WIRE) Ultraviolet Devices, Inc. (UVDI), a global leader in UV-C surface disinfecting and indoor air quality products, today announced its first Italian hospital studies […]
Dr. Anthony Fauci Joined by C-Level Executives from IBM, Goldman Sachs, Carlyle Group, Mayo Clinic, and Ford, as well as Gov. of Mississippi and Miami Mayor, to Present at Everbridge’s Symposium, COVID-19: Road to Recovery, Oct. 14-15, 2020
Marquee Lineup Features Keynotes from a Former World Leader, Sir Richard Branson, Dr. Sanjay Gupta, Dr. Anthony Fauci and C-Level Speakers from Top Business, Government and Healthcare Organizations Addressing Global […]
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagnostics Technology To Track Pathogenic Genome
29/09/2020 — NEW YORK, LONDON, & PARIS — (BUSINESS WIRE) Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on […]
Former World Head of State to Address Attendees at Everbridge’s COVID-19: Road to Recovery (R2R) Symposium, Joining Dr. Anthony Fauci, Sir Richard Branson, and Dr. Sanjay Gupta as Keynotes, October 14-15, 2020
Former World Head of State to Address Attendees at Everbridge’s COVID-19: Road to Recovery (R2R) Symposium, Joining Dr. Anthony Fauci, Sir Richard Branson, and Dr. Sanjay Gupta as Keynotes, October […]
Disruptive.Asia Comments on How Huawei and ONDE Are Helping Thailand Fight COVID-19 and Go Digital at the Same Time
03/08/2020 — LONDON — (BUSINESS WIRE) Disruptive.Asia has talked to Vunnaporn Devahastin, Secretary General of the Office of the National Digital Economy and Society Commission (ONDE) of Thailand, which is […]
Aptorum Group Prospectus Receives Approval for Listing on the Euronext Paris Stock Exchange
17/07/2020 — NEW YORK — (BUSINESS WIRE) Regulatory News: Aptorum Group Limited (Nasdaq:APM) (“Aptorum Group”), a biopharmaceutical company focusing on the development of novel therapeutics to address global unmet medical needs, […]
NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19
With resurgent COVID-19, enrollment has accelerated in Miami, Houston, and Irvine Data Monitoring Committee determined that so far RLF-100 has generated no drug-related Serious Adverse Events or other safety concerns […]
Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate
Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate First doses administered to human volunteers 15/07/2020 — QUEBEC CITY — (BUSINESS WIRE) Medicago, a biopharmaceutical company headquartered in […]
AmbioPharm Inc. Expands Peptide Production Helping Fight Against Covid-19
30/06/2020 — NORTH AUGUSTA, S.C. — (BUSINESS WIRE) AmbioPharm Inc. a leading supplier of peptide active pharmaceutical ingredients has recently opened its new manufacturing and quality control facilities at its […]
NeuroRx and Relief Therapeutics Announce Fast Track Designation Granted by the FDA to RLF-100 (Aviptadil) for the Treatment of Respiratory Distress in COVID-19
Fast Track Designation of RLF-100 for the treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome associated with COVID-19 underscores the urgent need for new treatment options for these patients. At […]
GenScript Biotech Announces CE-IVD for Its Neutralizing Antibody Test Kit of SARS-CoV-2 and COVID-19 Diagnostic Products
26/05/2020 — LEIDEN, The Netherlands — (BUSINESS WIRE) GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in […]
Everbridge Unveils New Contact Tracing Software to Contain and Mitigate COVID-19 While Facilitating the Safe Return to Work for Business, Government and Healthcare Organizations
Next Generation, End-to-End Contact Tracing Solution Provides Faster, More Accurate Results for Less Cost to Organizations While Safeguarding Individual Privacy to De-Risk the Return-to-Work Phase of the Coronavirus Pandemic 19/05/2020 […]
Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control
New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus 16/03/2020 — AUSTIN, Texas — (BUSINESS WIRE) Asuragen, Inc. has developed an Armored RNA Quant® […]
Nearly 2 Million Airline Seats Affected by New Travel Ban, According to OAG Analysis
10.9% of all U.S. international flights and 16.9% of scheduled U.S. international seats will be affected 12/03/2020 — LONDON & SINGAPORE — (BUSINESS WIRE) OAG, the world’s leading provider of […]
Medicago Announces Production of a Viable Vaccine Candidate for COVID-19
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease […]
ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV
21/12/2019 — LONDON — (BUSINESS WIRE) ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, received a complete response letter […]
Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases
24/04/2019 — SINGAPORE — (BUSINESS WIRE) Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (“SmartP”), which operates its novel computational repurposed drug […]
Powering Precision Health Announces Inaugural European Summit in Amsterdam December 12-13, 2018
Thought leaders convene to discuss research advances disrupting healthcare, including breakthroughs with blood-based Neurofilament light (NfL) in neurodegenerative diseases 05/12/2018 — LEXINGTON, Mass. & AMSTERDAM — (BUSINESS WIRE) Powering Precision […]
Asuragen Launches Assay to Aid in the Diagnosis of Myotonic Dystrophy Type I (DM1)
The AmplideX® DM1 Dx Kit is now available in countries accepting the CE mark 04/12/2018 — AUSTIN, Texas — (BUSINESS WIRE) Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products […]
PMC Group International Announces Acquisition of Pharma Company in France
05/12/2017 — MOUNT LAUREL, N.J. — (BUSINESS WIRE) PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group Inc., announced […]
European Commission Grants Marketing Authorisation for MSD’s ZEPATIER™ (elbasvir/grazoprevir) for the Treatment of Chronic Hepatitis C Infection
In Phase 3 Clinical Trials, ZEPATIER Achieved High Cure (SVR) Rates Across Diverse Populations of Patients With Chronic Hepatitis C, Including Those With Compensated Cirrhosis, Renal Impairment or on Opioid […]
MSD Provides Update on European Medicines Agency Marketing Authorisation Application for Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir
MSD, known as Merck (NYSE:MRK) in the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has responded to the company’s marketing authorisation application (MAA) for elbasvir/grazoprevir (50mg/100mg), which is under review for the treatment of adult patients with chronic hepatitis C (HCV) infection. The CHMP advised MSD that the application will now be reviewed on a standard timetable, rather than the accelerated assessment timeline previously announced. Under the revised timeline, MSD anticipates a European Commission decision in mid-2016.
Merck Honored by R&D Magazine for Innovation
16/12/2015 — DARMSTADT, Germany — (BUSINESS WIRE)
Merck, a leading science and technology company, today announced it has received two prestigious R&D Magazine 100 awards – one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn’t address. “Our researchers are relentlessly curious – aiming to provide the highest quality and most innovative products that solve the toughest problems in life science,” said Udit Batra, President and CEO of the life science business of Merck. “We will continue to drive future advancements within our expansive portfolio. I am most appreciative of our colleagues who have dedicated their careers to these efforts.”